Penn Pharma has appointed Carlo Truppi as US business development manager to lead efforts into increasing its business from US companies.
The UK-based provider of pharmaceutical development and manufacturing services said Truppi’s work would mainly involve working with pharma companies operating in the east coast of North America to boost business at Penn’s newly launched manufacturing site in south Wales, UK.
Truppi has more than a decade’s experience in pharmaceutical services, and was most recently director of business development at Bilcare Global Clinical Supplies.
He said: “The investment we are making is set to catapult Penn into new markets by providing key players in the industry with a specialist technology led contained facility in which to manufacture highly potent drugs. I am delighted at the prospect of being at the forefront of these discussions.”
Penn’s chief executive Dr Richard Yarwood said: “Carlo is going to play a pivotal role in finding business for our recently constructed contained manufacturing operation, which is due to open in Q1 2013. His broad experience in the industry will be invaluable to us as we grow our capability in processing highly potent drug products.’’